Youths' and their parents' attitudes and experiences about participation in psychopharmacology treatment research

Karen Wagner, Melissa Martinez, Thomas Joiner

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective: This study was designed to prospectively assess youths' and their parents' attitudes and experiences about participation in clinical treatment research. Method: Pre- and postquestionnaires were administered to 90 youths ages 6-17 years with psychiatric disorders who participated in clinical treatment studies and their parents between August 2000 and March 2004. Results: The majority of youths (63%) and parents (90%) reported that finding out about the youth's problem and receiving treatment were the main reasons for participation in the clinical treatment studies. Percentage of youths and parents, respectively, who confirmed that informed consent issues were discussed were: Purpose of study (96%, 100%), study procedures (94%, 100%), alternative treatment (62%, 94%), and voluntary participation (89%, 99%). Most youths liked their treatment (98%), believed the study proceeded as expected (67%), were glad to have participated in this study (94%), and would participate in another study (65%). Most parents believed the quality of care was good (90%), the study proceeded as expected (96%), and were glad their child participated (99%). Conclusions: The majority of youths and parents had a positive view about their experiences of participating in clinical treatment research, independent of whether or not the youth's psychiatric condition improved.

Original languageEnglish (US)
Pages (from-to)298-307
Number of pages10
JournalJournal of Child and Adolescent Psychopharmacology
Volume16
Issue number3
DOIs
StatePublished - Jun 2006

Fingerprint

Psychopharmacology
Parents
Research
Therapeutics
Psychiatry
Quality of Health Care
Informed Consent

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Pediatrics, Perinatology, and Child Health
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Youths' and their parents' attitudes and experiences about participation in psychopharmacology treatment research. / Wagner, Karen; Martinez, Melissa; Joiner, Thomas.

In: Journal of Child and Adolescent Psychopharmacology, Vol. 16, No. 3, 06.2006, p. 298-307.

Research output: Contribution to journalArticle

@article{bfbdc0b6b7224266a64ddb33197197d4,
title = "Youths' and their parents' attitudes and experiences about participation in psychopharmacology treatment research",
abstract = "Objective: This study was designed to prospectively assess youths' and their parents' attitudes and experiences about participation in clinical treatment research. Method: Pre- and postquestionnaires were administered to 90 youths ages 6-17 years with psychiatric disorders who participated in clinical treatment studies and their parents between August 2000 and March 2004. Results: The majority of youths (63{\%}) and parents (90{\%}) reported that finding out about the youth's problem and receiving treatment were the main reasons for participation in the clinical treatment studies. Percentage of youths and parents, respectively, who confirmed that informed consent issues were discussed were: Purpose of study (96{\%}, 100{\%}), study procedures (94{\%}, 100{\%}), alternative treatment (62{\%}, 94{\%}), and voluntary participation (89{\%}, 99{\%}). Most youths liked their treatment (98{\%}), believed the study proceeded as expected (67{\%}), were glad to have participated in this study (94{\%}), and would participate in another study (65{\%}). Most parents believed the quality of care was good (90{\%}), the study proceeded as expected (96{\%}), and were glad their child participated (99{\%}). Conclusions: The majority of youths and parents had a positive view about their experiences of participating in clinical treatment research, independent of whether or not the youth's psychiatric condition improved.",
author = "Karen Wagner and Melissa Martinez and Thomas Joiner",
year = "2006",
month = "6",
doi = "10.1089/cap.2006.16.298",
language = "English (US)",
volume = "16",
pages = "298--307",
journal = "Journal of Child and Adolescent Psychopharmacology",
issn = "1044-5463",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Youths' and their parents' attitudes and experiences about participation in psychopharmacology treatment research

AU - Wagner, Karen

AU - Martinez, Melissa

AU - Joiner, Thomas

PY - 2006/6

Y1 - 2006/6

N2 - Objective: This study was designed to prospectively assess youths' and their parents' attitudes and experiences about participation in clinical treatment research. Method: Pre- and postquestionnaires were administered to 90 youths ages 6-17 years with psychiatric disorders who participated in clinical treatment studies and their parents between August 2000 and March 2004. Results: The majority of youths (63%) and parents (90%) reported that finding out about the youth's problem and receiving treatment were the main reasons for participation in the clinical treatment studies. Percentage of youths and parents, respectively, who confirmed that informed consent issues were discussed were: Purpose of study (96%, 100%), study procedures (94%, 100%), alternative treatment (62%, 94%), and voluntary participation (89%, 99%). Most youths liked their treatment (98%), believed the study proceeded as expected (67%), were glad to have participated in this study (94%), and would participate in another study (65%). Most parents believed the quality of care was good (90%), the study proceeded as expected (96%), and were glad their child participated (99%). Conclusions: The majority of youths and parents had a positive view about their experiences of participating in clinical treatment research, independent of whether or not the youth's psychiatric condition improved.

AB - Objective: This study was designed to prospectively assess youths' and their parents' attitudes and experiences about participation in clinical treatment research. Method: Pre- and postquestionnaires were administered to 90 youths ages 6-17 years with psychiatric disorders who participated in clinical treatment studies and their parents between August 2000 and March 2004. Results: The majority of youths (63%) and parents (90%) reported that finding out about the youth's problem and receiving treatment were the main reasons for participation in the clinical treatment studies. Percentage of youths and parents, respectively, who confirmed that informed consent issues were discussed were: Purpose of study (96%, 100%), study procedures (94%, 100%), alternative treatment (62%, 94%), and voluntary participation (89%, 99%). Most youths liked their treatment (98%), believed the study proceeded as expected (67%), were glad to have participated in this study (94%), and would participate in another study (65%). Most parents believed the quality of care was good (90%), the study proceeded as expected (96%), and were glad their child participated (99%). Conclusions: The majority of youths and parents had a positive view about their experiences of participating in clinical treatment research, independent of whether or not the youth's psychiatric condition improved.

UR - http://www.scopus.com/inward/record.url?scp=33745154140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745154140&partnerID=8YFLogxK

U2 - 10.1089/cap.2006.16.298

DO - 10.1089/cap.2006.16.298

M3 - Article

VL - 16

SP - 298

EP - 307

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

SN - 1044-5463

IS - 3

ER -